Inflammatory Bowel Disease Phenotypes Vary by Race, Birthplace

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 8, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 8, 2024 -- For patients with inflammatory bowel disease (IBD), phenotype varies by race, and foreign-born patients of all races have later onset and milder disease, according to a study published online Dec. 16 in Gastro Hep Advances.

Ali Khalessi, M.D., from the New York University School of Medicine in New York City, and colleagues conducted a single-center retrospective review of all IBD inpatients and outpatients treated from 1997 to 2017 to examine how race/ethnicity and immigration status influence IBD manifestations, treatments, and outcomes. The analysis included 577 patients: 29.8, 27.4, 21.7, and 13.0 percent White, Hispanic, Black, and Asian, respectively.

The researchers found that Asian patients were more likely than White patients to be male (odds ratio [OR], 2.63), and Black patients were more likely to be diagnosed with Crohn disease and to undergo IBD-related intestinal resection (ORs, 1.75 and 2.49, respectively). Foreign-born patients were more likely to be diagnosed with ulcerative colitis than U.S.-born patients (OR, 1.77), and they were less likely to be diagnosed before age 16 years (OR, 0.19). They were also less likely to have undergone intestinal resections, received biologics, or dermatologic manifestations (ORs, 0.39. 0.43, and 0.12, respectively).

"Further studies to mechanistically understand the reason for differential IBD risk and presentation in certain races and among immigrant patients may provide new insights into IBD pathogenesis," the authors write. "This can in turn help guide disease prognostication and management in a growing and diversifying IBD patient population."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-09 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords